RESEARCH TRIANGLE PARK, N.C. – June 16, 2015 – Quintiles,the world’s largest biopharmaceutical services company, is extending its award-winning Quintiles Infosario® technology platform with mobile access to critical clinical trial information. Using the mobile app, key stakeholders in the drug development process can conveniently access site start-up, recruitment and compliance information as well as status updates on data queries and project milestones.
“With so much at stake in the successful delivery of development programs, faster decision making is fundamental,” said Margaret Keegan, senior vice president of Data Sciences & Strategy at Quintiles. “Infosario One provides instant and intuitive access to insights at your fingertips, wherever and whenever you need them.”
The Infosario One mobile app can be personalized with different filters so users can quickly see precisely what’s most important to them. These customized views are then served up in mobile-friendly charts that automatically reflect the latest information.
“Increasing complexity in the delivery of clinical trials - and the related information overload - can slow down progress or obscure valuable information,” said Alejandro Martinez, chief information officer at Quintiles. “We are committed to innovation that simplifies the complex, so this app provides not just easy access but at-a-glance transparency into study progress.”
The Infosario One mobile app will initially be available for download at the Apple App Store.
Quintiles’ experts will demo the app at its booth at the upcoming Drug Information Association (DIA) conference June 14-18, 2015 in Washington, D.C. For more information about Quintiles Infosario One, visit the Quintiles booth at DIA (#601) or www.quintiles.com/infosario-one.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.